<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">IJOHNS</journal-id><journal-title-group><journal-title>International Journal of Otolaryngology and Head &amp; Neck Surgery</journal-title></journal-title-group><issn pub-type="epub">2168-5452</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ijohns.2023.122008</article-id><article-id pub-id-type="publisher-id">IJOHNS-123702</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Acute Mastoiditis Clinical Course and Management in Patients Presented to Khartoumar Ear, Nose and Throat Hospital during the Period from November 2017 to November 2019
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mohamed</surname><given-names>Hanafi Elkhalifa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mohamed</surname><given-names>Elawad</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sief</surname><given-names>Mehnab</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Otorhinolaryngology Department, Khartoum Ear, Nose and Throat Hospital, Khartoum, Sudan</addr-line></aff><pub-date pub-type="epub"><day>06</day><month>03</month><year>2023</year></pub-date><volume>12</volume><issue>02</issue><fpage>69</fpage><lpage>84</lpage><history><date date-type="received"><day>19,</day>	<month>September</month>	<year>2022</year></date><date date-type="rev-recd"><day>13,</day>	<month>March</month>	<year>2023</year>	</date><date date-type="accepted"><day>16,</day>	<month>March</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: Acute mastoiditis is the most common complication of Acute Otitis Media (AOM) and it’s the cause of serious morbidity. There is no standard universally agreed-upon management approach to acute mastoiditis. This study aims to view the clinical presentation and management approaches in Khartoum Ear, Nose and Throat Hospital. 
  Methodology: This is a prospective case series and a hospital-based study conducted at Khartoum Ear, Nose and Throat Hospital during the period from November 2017 to November 2019. A total of 61 patients were included in the study. 
  Results: The median age at presentation is 5 years old, males are more affected than females with a ratio of 1.35:1, and the mean duration of symptoms prior to hospital admission was 9.6 days. The most common presenting symptoms were otalgia (83.3%), ear discharge (83.3%) and post-auricular swelling (83.3%), and the most common signs at admission were tenderness over the mastoid (95.1%), retroauricular swelling and protrusion of the auricle (82%), and redness over the mastoid (77%). The abnormal tympanic membrane was found in all patients with central perforation being the commonest finding (73.8%), and bulging tympanic membrane (21.3%). 34.4% of patients received oral antibiotics before admission and the mean duration of symptoms prior to admission increased significantly in those who received antibiotics 12.7 days in comparison to those who didn’t 8.3 days. Only 52.5% of patients had a past history of recurrent acute otitis media, and 8.2% had a past history of acute mastoiditis. All the patients with recurrent mastoiditis had a past history of recurrent acute otitis media. Computed Tomography (CT) scans were obtained for 50.8% and 83.9% of those scans showed coalescent mastoiditis. Further evidence of intracranial extension was found in 6.5% and Magnetic Resonance Imaging (MRI) was obtained for them. Of the study group, 67.2% presented with subperiosteal abscess, 4.9% with facial nerve palsy and 3.3% with brain abscess. Thirteen patients with no complications were managed initially with injectable and topical antibiotics and were successful in only 6 of them (46%), abscess incisions and drainages were needed in 46 patients and were successful in 34 of them (73.9%). Eighteen patients (29.5%) needed mastoidectomy and all of them were managed successfully (100%). One patient (1.6%) was referred for intracranial abscess drainage in a specialized hospital, also one patient (1.6%) initially presented with intracranial abscess died on the second day of admission and 96.8% were discharged in good condition. The mean duration of hospital stay was 7.5 days. 
  Conclusion: Patients present to the hospital after a prolonged period with a higher rate of complications, and the delayed presentation increased significantly in patients who received oral antibiotics prior to admission. Conservative medical treatment in non-complicated acute mastoiditis was ineffective in more than half of the patients and abscess incision and drainage and/or mastoidectomy are often necessary for the management.
 
</p></abstract><kwd-group><kwd>Mastoiditis</kwd><kwd> Acute Otitis Media</kwd><kwd> Mastoidectomy</kwd><kwd> Mastoid Abscess</kwd><kwd> Khartoum</kwd><kwd> Ear</kwd><kwd> Nose and Throat</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Acute mastoiditis is the infectious inflammation of the mastoid bone and it is the most common complication of AOM. True mastoiditis as a complication of AOM implies an invasive or persistent infection involving the mastoid bone and/or surrounding structures [<xref ref-type="bibr" rid="scirp.123702-ref1">1</xref>] .</p><p>Prior antibiotic treatment of AOM does not seem to protect from acute mastoiditis, and there is no significant difference in prior antibiotic use between those who developed a subperiosteal abscess and those who did not [<xref ref-type="bibr" rid="scirp.123702-ref2">2</xref>] .</p><p>Diagnosis usually rests on the presence of post-auricular swelling, protrusion of the pinna, post-auricular erythema and tenderness [<xref ref-type="bibr" rid="scirp.123702-ref3">3</xref>] . Patients usually present with fever, but it is less common in those treated with antibiotics [<xref ref-type="bibr" rid="scirp.123702-ref2">2</xref>] .</p><p>Initial workup involves a thorough history and physical examination, paying close attention to signs of more severe infection (toxic appearance, neurological changes, neck stiffness, no improvement after 48 hours of antibiotics) [<xref ref-type="bibr" rid="scirp.123702-ref4">4</xref>] also Laboratory markers such as C&#173;Reactive Protein (CRP) and White Blood Cell (WBC) counts are usually elevated [<xref ref-type="bibr" rid="scirp.123702-ref5">5</xref>] .</p><p>The role of radiology becomes extremely important in diagnosing the complications of mastoiditis which can be serious and life-threatening [<xref ref-type="bibr" rid="scirp.123702-ref6">6</xref>] . Acute mastoiditis is mainly a disease of childhood and exposing a child’s brain to the risk of ionizing radiation leads many authors to question the real indications for CT scan imaging in the setting of acute mastoiditis.</p><p>Classical treatment consisted of routine imaging and cortical mastoidectomy. However, in the last years, more conservative measures have been employed with success. The conservative approaches include treatment with intravenous antibiotics alone, or in combination with myringotomy or without pressure equalization tube placement. The presence of a subperiosteal abscess, historically requiring mastoidectomy has also been treated conservatively via incision and drainage or needle aspiration [<xref ref-type="bibr" rid="scirp.123702-ref4">4</xref>] .</p><p>This study aims to view the clinical presentation and management approaches in Khartoum ENT Hospital.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Study Design</title><p>This study included patients of all ages who presented to Khartoum Ear, Nose and Throat Hospital with acute mastoiditis between November 2017 and November 2019; all patients with chronic mastoiditis or previous ear surgery were excluded from the study. The subjects consisted of 61 patients with a mean age of 7.9 years. History, examination, investigations and in-hospital management modalities data were collected using a unified structured data collection sheet designed to address the study objectives. CT scan was obtained for 50.8% of our study group and the indications were suspicion of complications, failure to improve on medical treatment and planning for mastoidectomy. Evidence of intracranial extension was found in 2 patients (6.5%) and MRI images were obtained for them.</p><p>Ethical clearance from Sudanese medical specialization board ethical committee and permission from the administration of the hospital has been obtained</p></sec><sec id="s2_2"><title>2.2. Data Analysis</title><p>Data was analyzed by Statistical Packages for Social Sciences (SPSS) 23.0 software. Categorical variable were presented as proportion out of available observations and comparison between subgroups using Chi-square test. Comparison between sub groups of continuous variables used t-test. P &lt; 0.05 was considered statistically significant. Microsoft Office 2010 has been used for graphs and tables.</p></sec></sec><sec id="s3"><title>3. Results</title><p>The study included sixty-one patients mean age of 7.9 years, <xref ref-type="fig" rid="fig1">Figure 1</xref> shows age distribution. Thirty-five patients (57.4%) were males and 26 (42.6%) were females with male to female ratio of 1.35:1. Thirty patients (49.2%) were from urban areas whereas 31 (50.8%) were from rural areas.</p><p>The presenting symptoms in order of frequency were otalgia in 83.3%, ear discharge in 83.3%, post-auricular swelling in 83.3%, fever in 63.9%, malaise in 45.9%, Hearing impairment in 32.8%, decreased appetite in 22.9%, headache in 21.3%, nasal blockage in 13%, nasal discharge in 11.5%, cough in 9.8%, vertigo in 9.8%, tinnitus in 8.2%, sore throat in 8.2%, mouth deviation in 4.9%, shortness of breath in 3.3%, diplopia in 1.6%, neck stiffness in 1.6% and 1.6% had deterioration of consciousness (<xref ref-type="table" rid="table1">Table 1</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Presenting symptoms in acute mastoiditis among the study group (n = 61). The duration of ear symptoms ranged between 1 and 21 days prior to admission with a mean of 9.6 days</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Presenting symptoms</th><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Otalgia</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >83.3%</td></tr><tr><td align="center" valign="middle" >Ear discharge</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >83.3%</td></tr><tr><td align="center" valign="middle" >Post-auricular swelling</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >83.3%</td></tr><tr><td align="center" valign="middle" >Fever</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >63.9%</td></tr><tr><td align="center" valign="middle" >Malaise</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >45.9%</td></tr><tr><td align="center" valign="middle" >Hearing loss</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >32.8%</td></tr><tr><td align="center" valign="middle" >Decreased appetite</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >22.9%</td></tr><tr><td align="center" valign="middle" >Headach</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >21.3%</td></tr><tr><td align="center" valign="middle" >Nasal blockage</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >13%</td></tr><tr><td align="center" valign="middle" >Nasal discharge</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >11.5%</td></tr><tr><td align="center" valign="middle" >Verigo</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >9.8%</td></tr><tr><td align="center" valign="middle" >Cough</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >9.8%</td></tr><tr><td align="center" valign="middle" >Tinnitus</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >8.2%</td></tr><tr><td align="center" valign="middle" >Sore throat</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >8.2%</td></tr><tr><td align="center" valign="middle" >Mouth deviation</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4.9%</td></tr><tr><td align="center" valign="middle" >SOB</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3.3%</td></tr><tr><td align="center" valign="middle" >Diplopia</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.6%</td></tr><tr><td align="center" valign="middle" >Deteriorated consciousness</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.6%</td></tr><tr><td align="center" valign="middle" >Neck stiffness</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.6%</td></tr></tbody></table></table-wrap><p>The duration of ear symptoms ranged between 1 and 21 days prior to admission with a mean of 9.6 days and a median of 8 days (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>Duration of ear symptoms prior to hospital admission in patients who received oral antibiotics increased significantly (p = 0.004), patients who didn’t receive medications presented after a mean of 8.3 days of the start of symptoms and those who received medications presented after a mean of 12.7 days (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>Thirty-two patients (52.45%) had a past history of AOM ranging from one to eight previous attacks; the mean was 2.9 attacks. Four patients (6.6%) had a history of bronchial asthma and 3 patients (4.9%) had a history of rhinusinusitis (<xref ref-type="table" rid="table4">Table 4</xref>).</p><p>Five patients (8.2%) had past history of acute mastoiditis and all of them had a history of recurrent AOM and this finding was statistically significant (p = 0.038) (<xref ref-type="table" rid="table5">Table 5</xref>).</p><p>Temperature at presentation with a mean of 37.7˚C, heart rate ranged from with a mean of 96.9 beats per minute and respiratory rate ranged between a mean of 20.8 breaths per minute (<xref ref-type="table" rid="table6">Table 6</xref>).</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Duration of symptoms in days prior to hospital admission among the study group (n = 61)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Duration (days)</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >From 1 - 3</td><td align="center" valign="middle" >15</td></tr><tr><td align="center" valign="middle" >From 4 - 7</td><td align="center" valign="middle" >39</td></tr><tr><td align="center" valign="middle" >From 8 - 14</td><td align="center" valign="middle" >31</td></tr><tr><td align="center" valign="middle" >From 15 - 21</td><td align="center" valign="middle" >15</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Cross tabulation between duration of symptoms prior to hospital admission and previous history of medication in the study group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Mean duration of symptoms prior to hospital admission (SD)</th><th align="center" valign="middle" >P-value (t-test)</th></tr></thead><tr><td align="center" valign="middle" >Past history of medications prior to admission ( n = 21)</td><td align="center" valign="middle" >12.67 days (5.607)</td><td align="center" valign="middle"  rowspan="2"  >0.004</td></tr><tr><td align="center" valign="middle" >No past history of medication prior to admission (n = 40)</td><td align="center" valign="middle" >8.25 days (5.234)</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Distribution of cases according to past medical history in the study group (n = 61)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Past history</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent (n = 61)</th></tr></thead><tr><td align="center" valign="middle" >Similar condition</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >8.2%</td></tr><tr><td align="center" valign="middle" >AOM</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >47.6%</td></tr><tr><td align="center" valign="middle" >Bronchial asthma</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >6.6%</td></tr><tr><td align="center" valign="middle" >Rhinosinusitis</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4.9%</td></tr><tr><td align="center" valign="middle" >None</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >32.7%</td></tr></tbody></table></table-wrap><p>The presenting signs in order of frequency were tenderness over the mastoid in 95.1%, retroauricular swelling in 82%, protrusion of the auricle in 82%, redness over the mastoid in 77%, purulent ear discharge in 71%, fluctuant retroauricular swelling in 67%, Sagging of the posterior canal in 47.5%, positive reservoir sign in 36.1%, enlarged CLN in 23%, granulation tissue in the external auditory canal in 15%, discharging mastoid sinus in 6.6%, unilateral LMN facial nerve palsy in 4.9% and 3.3% presented with localizing neurological signs (<xref ref-type="table" rid="table7">Table 7</xref>).</p><p>The tympanic membrane showed pathological features in all patients. Central perforation is present in 73.8%, bulging in 21.3%, attic perforation in 3.3% and</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Cross tabulation between patients with past history of acute otitis media and patients with past history of similar condition among the study group (n = 61)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="2"  ></th><th align="center" valign="middle"  colspan="2"  >Past history of recurrent AOM</th><th align="center" valign="middle"  rowspan="2"  >Total</th></tr></thead><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >No</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Past history of similar condition</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >5</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >56</td></tr></tbody></table></table-wrap><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Shows vital signs at presentation among the study group (n = 61)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Vital signs</th><th align="center" valign="middle" >Minimum</th><th align="center" valign="middle" >Maximum</th><th align="center" valign="middle" >Mean</th><th align="center" valign="middle" >Std. deviation</th></tr></thead><tr><td align="center" valign="middle" >Temperature</td><td align="center" valign="middle" >37.00˚C</td><td align="center" valign="middle" >39.00˚C</td><td align="center" valign="middle" >37.7525</td><td align="center" valign="middle" >0.6454</td></tr><tr><td align="center" valign="middle" >Pulse</td><td align="center" valign="middle" >80 b/m</td><td align="center" valign="middle" >120</td><td align="center" valign="middle" >96.93</td><td align="center" valign="middle" >10.672</td></tr><tr><td align="center" valign="middle" >Respiratory rate</td><td align="center" valign="middle" >13 c/m</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >20.82</td><td align="center" valign="middle" >4.577</td></tr></tbody></table></table-wrap><table-wrap id="table7" ><label><xref ref-type="table" rid="table7">Table 7</xref></label><caption><title> Distribution of examination findings among the study group (n = 61)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Signs</th><th align="center" valign="middle" >Frequency (n = 61)</th><th align="center" valign="middle" >Percent</th></tr></thead><tr><td align="center" valign="middle" >Tenderness over the mastoid</td><td align="center" valign="middle" >58</td><td align="center" valign="middle" >95.1%</td></tr><tr><td align="center" valign="middle" >Retroauricular swelling</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >82%</td></tr><tr><td align="center" valign="middle" >Protrusion of the auricle</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >82%</td></tr><tr><td align="center" valign="middle" >Redness over the mastoid</td><td align="center" valign="middle" >47</td><td align="center" valign="middle" >77%</td></tr><tr><td align="center" valign="middle" >Purulent ear discharge</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >71%</td></tr><tr><td align="center" valign="middle" >Fluctuant retroauricular swelling</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >67%</td></tr><tr><td align="center" valign="middle" >Sagging of the post canal wall</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >48%</td></tr><tr><td align="center" valign="middle" >Positive reservoir sign</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >36%</td></tr><tr><td align="center" valign="middle" >Enlarged CLN</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >23%</td></tr><tr><td align="center" valign="middle" >Granulation in EC</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >15%</td></tr><tr><td align="center" valign="middle" >Mastoid discharging sinus</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >7%</td></tr><tr><td align="center" valign="middle" >FN palsy</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >5%</td></tr><tr><td align="center" valign="middle" >Localizing neurological signs</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3.3%</td></tr></tbody></table></table-wrap><p>retracted tympanic membrane in only 1.6% (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>Investigations at presentation showed white blood cell count with a mean of 15.1 &#215; 10<sup>3</sup> cell/mm<sup>3</sup>, hemoglobin with a mean of 10.7 mg/dl and ESR with a mean of 63.39 mm/hr (<xref ref-type="table" rid="table8">Table 8</xref>).</p><p>CT scan was done to 31 patients (50.8%), it showed mastoid cortex erosion and subcutaneous abcess in 48.4% (n = 31), lost mastoid bony trabeculae and intact cortex in 22.6%, middle ear cleft opacity with intact bony trabeculae and intact ossicles in 16.1%, mastoid opacity and eroded ossicles in 6.45% (<xref ref-type="table" rid="table9">Table 9</xref>).</p><p>Two scans (6.5%) showed evidence of intracranial extension and MRI was obtained for them and it showed cerebellar abscess in one case and temporal lobe abscess in the other.</p><p>Forty-six patients (75.4%) had complications with mastoiditis at presentation, 67.2% presented with subperiosteal abscess, 6.6% with a discharging mastoid sinus, 4.9% presented with facial nerve palsy and 3.3% presented with brain abscess (<xref ref-type="table" rid="table1">Table 1</xref>0).</p><table-wrap id="table8" ><label><xref ref-type="table" rid="table8">Table 8</xref></label><caption><title> Investigations results at presentation among the study group (n = 61)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Investigation</th><th align="center" valign="middle" >N</th><th align="center" valign="middle" >Minimum</th><th align="center" valign="middle" >Maximum</th><th align="center" valign="middle" >Mean</th><th align="center" valign="middle" >Std. deviation</th></tr></thead><tr><td align="center" valign="middle" >Hemoglobin</td><td align="center" valign="middle" >61</td><td align="center" valign="middle" >6.10</td><td align="center" valign="middle" >13.50</td><td align="center" valign="middle" >10.6836</td><td align="center" valign="middle" >1.82247</td></tr><tr><td align="center" valign="middle" >White blood cell count</td><td align="center" valign="middle" >61</td><td align="center" valign="middle" >6.10</td><td align="center" valign="middle" >22.00</td><td align="center" valign="middle" >15.1230</td><td align="center" valign="middle" >3.46273</td></tr><tr><td align="center" valign="middle" >Erythrocyte sedimentation rate</td><td align="center" valign="middle" >61</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >120</td><td align="center" valign="middle" >63.39</td><td align="center" valign="middle" >26.349</td></tr></tbody></table></table-wrap><table-wrap id="table9" ><label><xref ref-type="table" rid="table9">Table 9</xref></label><caption><title> Computed tomography findings in the study group (n = 31)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >CT scan findings</th><th align="center" valign="middle" >Frequency (n = 31)</th><th align="center" valign="middle" >Percent</th></tr></thead><tr><td align="center" valign="middle" >Middle ear and mastoid opacity, intact bony trabeculae and ossicles</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >16.1%</td></tr><tr><td align="center" valign="middle" >Lost trabeculae and preserved ossicles</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >22.6%</td></tr><tr><td align="center" valign="middle" >Eroded ossicles</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >6.45%</td></tr><tr><td align="center" valign="middle" >Cortex erosion and subcutaneous extension</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >48.4%</td></tr><tr><td align="center" valign="middle" >Intracranial extension</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >6.45%</td></tr></tbody></table></table-wrap><p>Thirteen patients presented with uncomplicated acute mastoidits was initially started on injectable antibiotics alone; 4 patients developed subperiosteal abscess during their hospital stay and needed incision and drainage, 3 patients didn’t improve after 48 hours of admission, one of them managed with maryngotomyinadition to antibiotics and 2 patients with evidence of coalescent mastoiditis on CT scan images required further cortical mastoidectomy. Only 6 patients (46%) (n = 13) was treated successfully with conservative treatment alone (<xref ref-type="table" rid="table1">Table 1</xref>1).</p><p>Fifty-three patients (86.9%) underwent surgical management (<xref ref-type="table" rid="table1">Table 1</xref>2), 46 of them (86.8%) (n = 53) underwent abscess incision and drainage and 34 of them (73.9%) (n = 46) were successfully managed. 12 patients (26.1%) (n = 46) required mastoidectomy after initial abscess drainage. Six patients (11.3%) underwent mastoidectomy as the initial management modality and all of them were successfully managed (<xref ref-type="table" rid="table1">Table 1</xref>2). Only one patient (1.9%) underwent myrigotomy</p><table-wrap id="table10" ><label><xref ref-type="table" rid="table1">Table 1</xref>0</label><caption><title> Frequency of patients presenting with complications of acute mastoiditis and AOM among the study group</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="5"  >Complications</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent (n = 61)</th></tr></thead><tr><td align="center" valign="middle"  colspan="2"   rowspan="2"  >Subperiostel abscess</td><td align="center" valign="middle" >With discharging mastoid sinus</td><td align="center" valign="middle"  colspan="2"  >4</td><td align="center" valign="middle"  rowspan="2"  >41</td><td align="center" valign="middle"  rowspan="2"  >67.2%</td></tr><tr><td align="center" valign="middle" >Without discharging mastoid sinus</td><td align="center" valign="middle"  colspan="2"  >37</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Facial nerve palsy</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4.9%</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Intracranial extention</td><td align="center" valign="middle"  colspan="3"  >Temporal lobe abscess</td><td align="center" valign="middle" >1</td><td align="center" valign="middle"  rowspan="2"  >2</td><td align="center" valign="middle"  rowspan="2"  >3.3%</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Cerebellar abscess</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table11" ><label><xref ref-type="table" rid="table1">Table 1</xref>1</label><caption><title> The percentage of cure rate in different treatment modalities in acute mastoiditisamong the study group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Modality of treatment</th><th align="center" valign="middle" >Cured</th><th align="center" valign="middle" >Failed</th><th align="center" valign="middle" >Percentage of cure rate</th></tr></thead><tr><td align="center" valign="middle" >Medical only (n = 13)</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >46% (n = 13)</td></tr><tr><td align="center" valign="middle" >Maryngotomy (n = 1)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >100% (n = 1)</td></tr><tr><td align="center" valign="middle" >Abscess incision and drainage (n = 46)</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >73.9% (n = 46)</td></tr><tr><td align="center" valign="middle" >Mastoidectomy (n = 18)</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >100% (n = 18)</td></tr></tbody></table></table-wrap><table-wrap id="table12" ><label><xref ref-type="table" rid="table1">Table 1</xref>2</label><caption><title> Surgical management modalities in acute mastoiditis patients in the study group (n = 53)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Surgical management</th><th align="center" valign="middle" >Frequency (n = 53)</th><th align="center" valign="middle" >Percent</th></tr></thead><tr><td align="center" valign="middle" >Abscess incision and drainage only</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >64.2%</td></tr><tr><td align="center" valign="middle" >Mastoidectomy only</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >11.3%</td></tr><tr><td align="center" valign="middle" >Abscess drainage followed by mastoidectomy</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >22.6%</td></tr><tr><td align="center" valign="middle" >Myringotomy</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.9%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >53</td><td align="center" valign="middle" >100%</td></tr></tbody></table></table-wrap><table-wrap id="table13" ><label><xref ref-type="table" rid="table1">Table 1</xref>3</label><caption><title> Outcome of acute mastoiditis in the study group (n = 61)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Outcome</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent</th></tr></thead><tr><td align="center" valign="middle" >Died</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.6%</td></tr><tr><td align="center" valign="middle" >Referred</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.6%</td></tr><tr><td align="center" valign="middle" >Improved and discharged</td><td align="center" valign="middle" >59</td><td align="center" valign="middle" >96.8%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >61</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap><table-wrap id="table14" ><label><xref ref-type="table" rid="table1">Table 1</xref>4</label><caption><title> Relation between modality of treatment and duration of hospital stay in successfully managed patients of acute mastoiditis among the study group (n = 59)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Modality of treatment</th><th align="center" valign="middle"  rowspan="2"  >Mean duration of hospital stay in days</th><th align="center" valign="middle"  rowspan="2"  >Std. deviation</th><th align="center" valign="middle" ></th></tr></thead><tr><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Medical only (n = 6)</td><td align="center" valign="middle" >5.33</td><td align="center" valign="middle" >1.366</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Abscess drainage (n = 34)</td><td align="center" valign="middle" >5.44</td><td align="center" valign="middle" >2.191</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Mastoidectomy (n = 18)</td><td align="center" valign="middle" >12.39</td><td align="center" valign="middle" >4.089</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Myrigotomy (n = 1)</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Total (n = 59)</td><td align="center" valign="middle" >7.52</td><td align="center" valign="middle" >4.373</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>without ventilation tube insertion.</p><p>Fifty-nine patients (96.8%) improved and discharged from the hospital in good condition, 1.6% referred to neurosurgical unit for drainage of intracranial abscess. 1.6% initially presented with cerebellar abscess died on the second day of admission (<xref ref-type="table" rid="table1">Table 1</xref>3).</p><p>Duration of hospital stay ranged from 2 and 21 days with a mean of 7.5 days, 12.4 days for the mastoidectomy patients, 5.4 days for patients managed with abscess incision and drainage in addition to medical treatment and 5.3 days for patients treated with injectable antibiotic (<xref ref-type="table" rid="table1">Table 1</xref>4).</p></sec><sec id="s4"><title>4. Discussion</title><p>This study found that the median age is 5 years and that’s closely related but slightly higher than Tawfik et al. [<xref ref-type="bibr" rid="scirp.123702-ref7">7</xref>] , Marchisio et al. [<xref ref-type="bibr" rid="scirp.123702-ref8">8</xref>] and Garcia et al.’s [<xref ref-type="bibr" rid="scirp.123702-ref9">9</xref>] studies (4.9, 4, 3.8 years respectively) which included only pediatric population.</p><p>Males were found to be affected in 57.4% of the cases with a male to female ratio of 1.35:1, thisresult is closely related to Thompson et al.’s [<xref ref-type="bibr" rid="scirp.123702-ref10">10</xref>] study who report that 57.6% of the cases were males. These results ware in favor with studies done in Eastern Denmark [<xref ref-type="bibr" rid="scirp.123702-ref11">11</xref>] , Sweden [<xref ref-type="bibr" rid="scirp.123702-ref12">12</xref>] , France [<xref ref-type="bibr" rid="scirp.123702-ref13">13</xref>] , Italy [<xref ref-type="bibr" rid="scirp.123702-ref8">8</xref>] , Greece [<xref ref-type="bibr" rid="scirp.123702-ref14">14</xref>] , Israel [<xref ref-type="bibr" rid="scirp.123702-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.123702-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.123702-ref17">17</xref>] and Tunisia [<xref ref-type="bibr" rid="scirp.123702-ref18">18</xref>] ; in which the male affection is slightly more than females. This may be due to the higher incidence of AOM in males as well as more recurrent episodes than females reported in some studies [<xref ref-type="bibr" rid="scirp.123702-ref1">1</xref>] .</p><p>The most common presenting symptoms in this study were otalgia, post-auricular swelling and fever in 83.3%, 83.3% and 63.9% respectively; and this is closely similar to the study done in Helsinki university central hospital [<xref ref-type="bibr" rid="scirp.123702-ref19">19</xref>] with similar number of cases (88%, 66% and 71% respectively), however, they report ear discharge in only 43% which is very low compared to our result of 83.3% of ear discharge which indicate that AM in our study occur mostly in the resolution phase of AOM. The mean of the duration of middle ear symptoms prior to admission was 9.6 days which is closely related to Laulajainen et al.’s study [<xref ref-type="bibr" rid="scirp.123702-ref19">19</xref>] who report 9.7 days but significantly longer than many other studies; in Luntz et al.’s [<xref ref-type="bibr" rid="scirp.123702-ref15">15</xref>] study, it was 6.9 days; in attlmyer B. et al. [<xref ref-type="bibr" rid="scirp.123702-ref20">20</xref>] , it was 5.1 days, 6.1 days in Psarmommatis et al. [<xref ref-type="bibr" rid="scirp.123702-ref14">14</xref>] and 5 days according to Tamir et al. [<xref ref-type="bibr" rid="scirp.123702-ref21">21</xref>] . This indicates a much delayed presentation in our patients after the onset of the symptoms.</p><p>The mean temperature at presentation was 37.7˚C which is slightly lower than Luntz et al. [<xref ref-type="bibr" rid="scirp.123702-ref15">15</xref>] study which was 38.1˚C. This could be attributed to the shorter duration of symptoms prior to admission in that study compared to ours (6.2 days vs. 9.6 days).</p><p>The most consistent presenting sign was tenderness over the mastoid in 95.1% followed by protrusion of the auricle in 82% and redness over the mastoid in 77%. These findings were consistent with other studies with slight variations; in Marom et al. [<xref ref-type="bibr" rid="scirp.123702-ref22">22</xref>] tenderness and eryhtema of the post-auricular region was found in 83% and protrusion of the auricle in 89%. In Abid et al. [<xref ref-type="bibr" rid="scirp.123702-ref18">18</xref>] , all children had some evidence of post-auricular inﬂammation (redness and/or swelling and/or tenderness) and most of them presented with auricular protrusion (84%).</p><p>All the patients in this study had abnormal tympanic membranes with perforations noted in 77.1% of them where as in other studies pathological redness and bulging but intact tympanic membranes was the most common finding. In Luntz et al. [<xref ref-type="bibr" rid="scirp.123702-ref15">15</xref>] , Abid et al. [<xref ref-type="bibr" rid="scirp.123702-ref18">18</xref>] and Marom et al. [<xref ref-type="bibr" rid="scirp.123702-ref22">22</xref>] , bulging of the tympanic membrane was found in 97%, 90.6% and 65% respectively. It was only found in 21.3% of our study group. This indicates a much advanced disease at presentation compared to other studies.</p><p>CT scan was obtained to 50.8% of our study group and the indications were suspicion of complications, failure to improve on medical treatment and planning for mastoidectomy. Of those scanned, 83.9% showed coalescent mastoiditis with further evidence of intracranial extension in only 6.5%. CT scans were obtained in 68% on average in literature ranging from 3% - 100% according to Van den Aardweg et al.’s [<xref ref-type="bibr" rid="scirp.123702-ref3">3</xref>] systematic review and our results fall in that range, however, the imaging was not routinely designed to assess both for mastoid coalescence and intracranial complications initially and that could explain the lower rate of intracranial complicalions in our study in patients with coalescent mastoiditis compared to Zevallos et al.’s [<xref ref-type="bibr" rid="scirp.123702-ref23">23</xref>] study findings (7.7% vs. 29.3%).</p><p>Forty-six patients (75.4%) had complications with mastoiditis at presentation this is related to 68.8% in the study of Abid et al. [<xref ref-type="bibr" rid="scirp.123702-ref18">18</xref>] in Tunisia, but its far more than only 22% of patients in Luntz et al.’s [<xref ref-type="bibr" rid="scirp.123702-ref15">15</xref>] study, 14.8% in Albaraznji et al.’s study [<xref ref-type="bibr" rid="scirp.123702-ref24">24</xref>] and 7.2% in Marchisio et al.’s [<xref ref-type="bibr" rid="scirp.123702-ref8">8</xref>] study. Subperiosteal abscess was the most prevalent in our study, in Abid et al. [<xref ref-type="bibr" rid="scirp.123702-ref18">18</xref>] and in Luntz et al.’s [<xref ref-type="bibr" rid="scirp.123702-ref15">15</xref>] study as well 67.2%, 59.4% and 16.6% respectively, 4.9% presented with facial nerve palsy compared to 1.5% in Luntz et al.’s [<xref ref-type="bibr" rid="scirp.123702-ref15">15</xref>] study and 2 patients (3.3%) presented with brain abscess compared to 7.2% in Luntz et al.’s [<xref ref-type="bibr" rid="scirp.123702-ref15">15</xref>] study.</p><p>Medical treatment only was given initially to 13 patients (21.3%) (n = 61) none of them presented with complication; it was successful in managing 6 patients (46%) (n = 13). Abscess incision and drainage was needed in 46 patients (75.4%) (n = 61) and was successful in the management of 34 patients (73.9%) (n = 46). Eighteen patients (29.5%) (n = 61) needed mastoidectomy and all of them were treated successfully (100%). This is in comparison to the systemic review conducted by Anne et al. [<xref ref-type="bibr" rid="scirp.123702-ref25">25</xref>] which found that the mean cure rate with intravenous antibiotics alone to be 71.7%, subperiosteal abscess incision and drainage in addition to maryngotomy achieved 94% cure rate and mastoidectomy 100% cure rate.</p><p>In Abid et al.’s [<xref ref-type="bibr" rid="scirp.123702-ref18">18</xref>] study, where 10 patients were managed with medical treatment only; 9 of them (90%) successfully and one needed mastoidectomy, subperiosteal abscess and drainage was the initial management in 11 patients with a success rate of 63.6% and in Aziz and El-Hoshy’s [<xref ref-type="bibr" rid="scirp.123702-ref26">26</xref>] study in Cairo university hospital, 5 patients initiated on ceftriaxone injection only were successfully treated (100%), all patients in their study who presented with subperiosteal abscess were managed with mastoidectomy and myrigotomy. In these studies, the authors found that initial medical treatment with empiric antibiotics is a sound option. In this study, the results indicate a low success rate of medical treatment alone in uncomplicated cases and we conclude that if medical treatment with empiric antibiotics is initiated; patients should be closely monitored and complications and failure of management be anticipated with an aversion to abscess incision and drainage and/or mastoidectomy when needed.</p><p>The mean duration of hospital stay in this study was 7.5 days, that’s comparable to In Marchisio’s study [<xref ref-type="bibr" rid="scirp.123702-ref8">8</xref>] mean of 7.1 days, Oestriecher-Kadem et al.’s [<xref ref-type="bibr" rid="scirp.123702-ref27">27</xref>] study result of 8.3 days and 8.5 days in Albaraznji et al. [<xref ref-type="bibr" rid="scirp.123702-ref24">24</xref>] .</p></sec><sec id="s5"><title>5. Conclusion</title><p>Patients present to the hospital after a prolonged period with a higher rate of complications, and the delayed presentation increased significantly in patients who received oral antibiotics prior to admission. Conservative medical treatment in non-complicated acute mastoiditis was ineffective in more than half of the patients and abscess incision and drainage and/or mastoidectomy are often necessary for the management.</p></sec><sec id="s6"><title>Limitations of the Study</title><p>The limitations of the study include the national data base for acute mastoiditis, making it difficult to determine the true prevalence of the disease. Additionally, the socioeconomic limitations of many patients prevented follow-up visits, as they were referred to Khartoum Ear, Nose and Throat Hospital from different regions in the country. This limited the ability to track the complete clinical course of acute mastoiditis, making it a challenge to gather comprehensive data on the disease.</p></sec><sec id="s7"><title>Acknowledgements</title><p>We gratefully acknowledge all teachers in this training program for their precious knowledge and teaching.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s9"><title>Cite this paper</title><p>Elkhalifa, M.H., Elawad, M. and Mehnab, S. (2023) Acute Mastoiditis Clinical Course and Management in Patients Presented to Khartoumar Ear, Nose and Throat Hospital during the Period from November 2017 to November 2019. International Journal of Otolaryngology and Head &amp; Neck Surgery, 12, 69-84. https://doi.org/10.4236/ijohns.2023.122008</p></sec><sec id="s10"><title>Appendix</title><p>Data collection sheet</p><p>Acute Mastoiditis Clinical Course and Management in Patients Presented to Khartoum ENT Hospital</p><p>General Information</p><p>Name: ______________________________________________________</p><p>Gender: Male ( ) Female ( ) Age: ( )</p><p>Occupation: _________________________________________________</p><p>Residence: Urban ( ) Rural ( )</p><p>Contact number: _____________________</p><p>Informer: ____________________________________________________</p><p>Date: ____________________________</p><p>Clinical Information: Write √ between the brackets site: Right side ( ) Left side ( ) Bilateral ( )</p><p>Duration ______________________________________________________</p><p>Presenting Symptoms</p><p>Ear pain ( ) Ear discharge ( ) Hearing impairment ( ) Vertigo ( ) Tinnitus ( )</p><p>Post-auricular swelling ( ) Nasal blockage ( ) Nasal discharge ( ) Sore throat ( )</p><p>Cough ( ) Shortness of breathing ( ) Fever ( ) Malaise ( )</p><p>Headache ( ) Decreased appetite/refusal of feeding ( ) Mouth deviation ( ) Diplopia ( ) Deteriorated consciousness ( ) Neck stiffness ( )</p><p>________________________________________________________________________________________________</p><p>________________________________________________________________________________________________</p><p>Past History</p><p>Past history of similar condition ( ) History of recurrent AOM ( ) Number of attacks of AOM ( )</p><p>History of immune compromise ( ) History of asthma ( ) History of DM ( )</p><p>History of Rhinosinusitis ( )</p><p>Family History</p><p>Family history of similar condition ( ) Family history of recurrent AOM ( )</p><p>Family history of bronchial asthma ( ) Family history of rhinosinusitis ( )</p><p>Drug History</p><p>Past Drug History 1______________ 2______________ 3______________</p><p>Current Medications 1______________ 2______________ 3______________</p><p>Clinical Examination</p><p>General Examination</p><p>Looks well ( ) Looks unwell ( ) Vital signs: temp ( ) Pulse () RR ( ) BP ( )</p><p>Nasal discharge ( ) Nasal polyp ( ) Inflamed pharynx ( ) Hypertrophied tonsils ( ) Postnasal dripping ( ) Enlarged cervical lymph nodes ( ) Neck rigidity ( ) Localizing neurological signs ( )</p><p>Other: __________________________________________________________________________________________</p><p>________________________________________________________________________________________________</p><p>Local Examination</p><p>Retro auricular Swelling ( ) Protrusion of the auricle ( ) Redness in the mastoid area ( )</p><p>Tenderness over the mastoid ( ) Fluctuant retroauricular swelling ( ) Mastoid discharging sinus ( )</p><p>Affected Facial nerve ( )</p><p>Otoscopic Examination</p><p>Ear Canal: Sagging of posterior canal wall ( ) Purulent discharge ( )</p><p>Tympanic Membrane: Intact normal ( ) Bulging ( ) Retracted ( )</p><p>Perforated tympanic membrane ( ): Central perforation ( )</p><p>Attic perforation ( ) Positive reservoir sign: ( )</p><p>Granulation tissue in the external canal and/or middle ear ( ) Cholestiatoma ( )</p><p>Hospital Management</p><p>Investigations</p><p>Laboratory:</p><p>CBC ( )</p><p>------------------------------------------------------------------------------------------------------------------------------------</p><p>------------------------------------------------------------------------------------------------------------------------------------</p><p>ESR ( )</p><p>------------------------------------------------------------------------------------------------------------------------------------</p><p>Radiology:</p><p>CT SCAN done ( )</p><p>Findings</p><p>------------------------------------------------------------------------------------------------------------------------------------</p><p>------------------------------------------------------------------------------------------------------------------------------------</p><p>MRI done ( )</p><p>Findings</p><p>------------------------------------------------------------------------------------------------------------------------------------</p><p>------------------------------------------------------------------------------------------------------------------------------------</p><p>Treatment Medical:</p><p>------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Surgical</p><p>Abcess drainage ( ) If yes: Initial management ( ) Following initial medical management ( )</p><p>Maryngotomy: ( ) If yes: Without ventilation tube ( ) With ventilation tube ( )</p><p>Mastoidectomy( ) If yes: Initial management ( ) Following initial medical management ( ) Following abscess incision and drainage ( )</p><p>Outcome</p><p>Improved and discharged ( ) Referred ( ) If yes: Reason for refer ____________________________________</p><p>In hospital complications: No ( ) Yes ( )</p><p>If yes: Extracranial complications ( )</p><p>------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Intracranial complications ( )</p><p>------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Died ( ) If yes: Cause of death______________________________________________________________________</p><p>Duration of hospital stay ( )</p></sec></body><back><ref-list><title>References</title><ref id="scirp.123702-ref1"><label>1</label><mixed-citation publication-type="book" xlink:type="simple">Arts, H.A. and Adams, M.E. (2014) Intratemporal and Intracranial Complications of Otitis Media. In: Hirsch, B.E. and Jackler, R.K., Eds., Bailay’s Head and Neck Surgery: Otolaryngology, 5th Edition, Wolters Klower, Lippincott Williams &amp; Wilkins, Philadelphia, 2402 p.</mixed-citation></ref><ref id="scirp.123702-ref2"><label>2</label><mixed-citation publication-type="book" xlink:type="simple">Rea, P.A. and Natalie Ronan, N.A. (2018) Acute Otitis Media. In: Watkinson, J.C. and Clarke, R.W., Eds., Scott-Brown’s Otolaryngology Head and Neck Surgery, 8th Edition, CRC Press, Boca Raton, 147 p. https://doi.org/10.1201/9780203731017-14</mixed-citation></ref><ref id="scirp.123702-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Van den Aardweg, M.T.A., Rovers, M.M., De Ru, J.A., Albers, F.W.J. and Schilder, A.G.M. (2008) A Systematic Review of Diagnostic Criteria for Acute Mastoiditis in Children. Otology &amp; Neurotology, 29, 751-757. https://doi.org/10.1097/MAO.0b013e31817f736b</mixed-citation></ref><ref id="scirp.123702-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Chesney, J., Black, A. and Choo, D. (2014) What Is the Best Practice for Acute Mastoiditis in Children? The Laryngoscope, 124, 1057-1058. https://doi.org/10.1002/lary.24306</mixed-citation></ref><ref id="scirp.123702-ref5"><label>5</label><mixed-citation publication-type="book" xlink:type="simple">Jethanamest, D. and Angeli, S.I. (2016) Complications of Temporal Bone Infection. In: Lalwani, A.K., Ed., Sataloff’s Comprehensive Textbook of Otolaryngology Head and Neck Surgery, 1st Edtion, Vol. 1, Jaypee Brothers Medical Publishers (P) Ltd., New Delhi, 219-230. https://doi.org/10.5005/jp/books/12689_14</mixed-citation></ref><ref id="scirp.123702-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Luntz, M., Bartal, K., Brodsky, A. and Shihada, R. (2012) Acute Mastoiditis: The Role of Imaging for Identifying Intracranial Complications. The Laryngoscope, 122, 2813-2817. https://doi.org/10.1002/lary.22193</mixed-citation></ref><ref id="scirp.123702-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Tawfik, K.O., Ishman, S.L., Tabangin, M.E., Altaye, M., Meinzen-Derr, J. and Choo, D.I. (2017) Pediatric Acute Mastoiditis in the Era of Pneumococcal Vaccination. The Laryngoscope, 128, 1480-1485. https://doi.org/10.1002/lary.26968</mixed-citation></ref><ref id="scirp.123702-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Marchisio, P., Bianchini, S., Villani, A., Verri, G., Bernardi, F., Porta, A., et al. (2014) Diagnosis and Management of Acute Mastoiditis in a Cohort of Italian Children. Expert Review of Anti-Infective Therapy, 12, 1541-1548. https://doi.org/10.1586/14787210.2014.982093</mixed-citation></ref><ref id="scirp.123702-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Garcia, C., Salgueiro, A.B., Luís, C., Correia, P. and Brito, M.J. (2017) Acute Mastoiditis in Children: Middle Ear Cultures May Help in Reducing Use of Broad Spectrum Antibiotics. International Journal of Pediatric Otorhinolaryngology, 92, 32-37. https://doi.org/10.1016/j.ijporl.2016.11.002</mixed-citation></ref><ref id="scirp.123702-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Thompson, P.L., Gilbert, R.E., Long, P.F., Saxena, S., Sharland, M. and Wong, I.C.K. (2009) Effect of Antibiotics for Otitis Media on Mastoiditis in Children: A Retrospective Cohort Study Using the United Kingdom General Practice Research Database. Pediatrics, 123, 424-430. https://doi.org/10.1542/peds.2007-3349</mixed-citation></ref><ref id="scirp.123702-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Anthonsen, K., H&amp;#248;stmark, K., Hansen, S., Andreasen, K., Juhlin, J., Hom&amp;#248;e, P., et al. (2013) Acute Mastoiditis in Children. The Pediatric Infectious Disease Journal, 32, 436-440. https://doi.org/10.1097/INF.0b013e31828abd13</mixed-citation></ref><ref id="scirp.123702-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Stenfeldt, K., Enoksson, F., Stalfors, J., Hultcrantz, M., Hermansson, A. and Groth, A. (2014) Infants under the Age of Six Months with Acute Mastoiditis. A Descriptive Study of 15 Years in Sweden. International Journal of Pediatric Otorhinolaryngology, 78, 1119-1122. https://doi.org/10.1016/j.ijporl.2014.04.027</mixed-citation></ref><ref id="scirp.123702-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Quesnel, S., Nguyen, M., Pierrot, S., Contencin, P., Manach, Y. and Couloigner, V. (2010) Acute Mastoiditis in Children: A Retrospective Study of 188 Patients. International Journal of Pediatric Otorhinolaryngology, 74, 1388-1392. https://doi.org/10.1016/j.ijporl.2010.09.013</mixed-citation></ref><ref id="scirp.123702-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Psarommatis, I.M., Voudouris, C., Douros, K., Giannakopoulos, P., Bairamis, T. and Carabinos, C. (2012) Algorithmic Management of Pediatric Acute Mastoiditis. International Journal of Pediatric Otorhinolaryngology, 76, 791-796. https://doi.org/10.1016/j.ijporl.2012.02.042</mixed-citation></ref><ref id="scirp.123702-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Luntz, M., Brodsky, A., Nusem, S., Kronenberg, J., Keren, G., Migirov, L., et al. (2001) Acute Mastoiditis—The Antibiotic Era: A Multicenter Study. International Journal of Pediatric Otorhinolaryngology, 57, 1-9. https://doi.org/10.1016/S0165-5876(00)00425-0</mixed-citation></ref><ref id="scirp.123702-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Amir, A.Z., Pomp, R. and Amir, J. (2013) Changes in Acute Mastoiditis in a Single Pediatric Tertiary Medical Center: Our Experience during 2008-2009 Compared with Data for 1983-2007. Scandinavian Journal of Infectious Diseases, 46, 9-13. https://doi.org/10.3109/00365548.2013.849814</mixed-citation></ref><ref id="scirp.123702-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">De, S., Makura, Z.G.G. and Clarke, R.W. (2002) Paediatric Acute Mastoiditis: The Alderly Hey Experience. The Journal of Laryngology &amp; Otology, 116, 440-442. https://doi.org/10.1258/0022215021911239</mixed-citation></ref><ref id="scirp.123702-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Abid, W., Gamra, O.B., Ghorbal, H., Cherif, I., Zribi, S., Hriga, I., et al. (2014) Management of Acute Mastoiditis in Children. A Retrospective Study and Literature Review. Egyptian Journal of Ear, Nose, Throat and Allied Sciences, 15, 205-209. https://doi.org/10.1258/0022215021911239</mixed-citation></ref><ref id="scirp.123702-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Laulajainen-Hongisto, A., Saat, R., Lempinen, L., Markkola, A., Aarnisalo, A.A. and Jero, J. (2014) Bacteriology in Relation to Clinical Findings and Treatment of Acute Mastoiditis in Children. International Journal of Pediatric Otorhinolaryngology, 78, 2072-2078. https://doi.org/10.1016/j.ijporl.2014.09.007</mixed-citation></ref><ref id="scirp.123702-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Attlmayr, B., Zaman, S., Scott, J., Derbyshire, S.G., Clarke, R.W. and De, S. (2015) Paediatric Acute Mastoiditis, Then and Now: Is It More of a Problem Now? The Journal of Laryngology &amp; Otology, 129, 955-959. https://doi.org/10.1017/S0022215115002078</mixed-citation></ref><ref id="scirp.123702-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Tamir, S., Schwartz, Y., Peleg, U., Perez, R. and Sichel, J.-Y. (2009) Acute Mastoiditis in Children: Is Computed Tomography Always Necessary? Annals of Otology, Rhinology &amp; Laryngology, 118, 565-569. https://doi.org/10.1177/000348940911800806</mixed-citation></ref><ref id="scirp.123702-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Marom, T., Roth, Y., Boaz, M., Shushan, S., Oron, Y., Goldfarb, A., et al. (2015) Acute Mastoiditis in Children: Necessity and Timing of Imaging. The Pediatric Infectious Disease Journal, 35, 30-34. https://doi.org/10.1097/INF.0000000000000920</mixed-citation></ref><ref id="scirp.123702-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Zevallos, J.P., Vrabec, J.T., Williamson, R.A., Giannoni, C., Larrier, D., Sulek, M., et al. (2009) Advanced Pediatric Mastoiditis with and without Intracranial Complications. The Laryngoscope, 119, 1610-1615. https://doi.org/10.1002/lary.20259</mixed-citation></ref><ref id="scirp.123702-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Albaraznji, S.M., AI Ansari, K. and Radi, M.M. (2014) Acute Mastoiditis in Children in the State of Qatar. Journal of Emergency Medicine, Trauma and Acute Care, 2014, Article No. 6. https://doi.org/10.5339/jemtac.2014.6</mixed-citation></ref><ref id="scirp.123702-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Anne, S., Schwartz, S., Ishman, S.L., Cohen, M. and Hopkins, B. (2019) Medical Versus Surgical Treatment of Pediatric Acute Mastoiditis: A Systematic Review. The Laryngoscope, 129, 754-760. https://doi.org/10.1002/lary.27462</mixed-citation></ref><ref id="scirp.123702-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Abdel-Aziz, M. and EI-Hoshy, H. (2010) Acute Mastoiditis: A One Year Study in the Pediatric Hospital of Cairo University. BMC Ear, Nose and Throat Disorders, 10, Article No. 1. https://doi.org/10.1186/1472-6815-10-1</mixed-citation></ref><ref id="scirp.123702-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Palma, S., Bovo, R., Benatti, A., Aimoni, C., Rosignoli, M., Libanore, M., et al. (2014) Mastoiditis in Adults: A 19-Year Retrospective Study. European Archives of Oto-Rhino-Laryngology, 271, 925-931. https://doi.org/10.1007/s00405-013-2454-8</mixed-citation></ref></ref-list></back></article>